Advertisement
UK markets closed
  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     
  • HANG SENG

    17,284.54
    +83.27 (+0.48%)
     
  • CRUDE OIL

    82.51
    -0.30 (-0.36%)
     
  • GOLD FUTURES

    2,341.40
    +3.00 (+0.13%)
     
  • DOW

    37,922.32
    -538.60 (-1.40%)
     
  • Bitcoin GBP

    51,250.12
    -563.74 (-1.09%)
     
  • CMC Crypto 200

    1,385.79
    +3.22 (+0.23%)
     
  • NASDAQ Composite

    15,490.54
    -222.21 (-1.41%)
     
  • UK FTSE All Share

    4,387.94
    +13.88 (+0.32%)
     

3 Stocks That Could Benefit From the Ozempic Craze

3 Stocks That Could Benefit From the Ozempic Craze

Ozempic is a drug that has been soaring in popularity over the past year. Three companies that can benefit from the excitement around this weight-loss treatments are Novo Nordisk (NYSE: NVO), Eli Lilly (NYSE: LLY), and WW International (NASDAQ: WW). The biggest benefactor of Ozempic's popularity is likely to be the company that makes the treatment itself: Novo Nordisk.